IMPACT OF RIFAXIMIN THERAPY ON ISCHEMIA REPERFUSION INJURY IN LIVER TRANSPLANTATION: A PROPENSITY SCORE-MATCHED ANALYSIS

Intestinal microbiota is thought to play an important role in hepatic ischemia/reperfusion injury (IRI) after liver transplantation (LT). Rifaximin, a nonabsorbable antibiotic used to treat encephalopathy exhibits antibacterial activity within the gut. We report the first study examining the impact...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Liver Transpl
Auteurs principaux: Ito, Takahiro, Nakamura, Kojiro, Kageyama, Shoichi, Korayem, Islam M., Hirao, Hirofumi, Kadono, Kentaro, Aziz, Justine, Younan, Stephanie, DiNorcia, Joseph, Agopian, Vatche G., Yersiz, Hasan, Farmer, Douglas G., Busuttil, Ronald W., Kupiec-Weglinski, Jerzy W., Kaldas, Fady M.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6887108/
https://ncbi.nlm.nih.gov/pubmed/31509643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lt.25633
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires